JIACRA III - Antimicrobial consumption and resistance in bacteria from humans and animals
Third joint inter-agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU/EEA.
Antimicrobial consumption - Annual Epidemiological Report for 2019
In 2019, the average total (community and hospital sector combined) consumption of antibacterials for systemic use (Anatomical Therapeutic Chemical (ATC) group J01) in the EU/EEA was 19.4 defined daily doses (DDD) per 1 000 inhabitants per day (country range: 9.5–34.1). During the period 2010–2019, a statistically significant decrease was observed for the EU/EEA overall.
Antibiotic Resistance - What can you do as a healthcare specialist?
We are facing the possibility of a future where antibiotics will no longer be effective due to the antimicrobial resistance. This video explains what healthcare specialists can do to prevent this.
Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in neisseria gonorrhoeae in 24 european countries: An ecological analysis
Kenyon, C., Buyze, J., Spiteri, G., Cole, M.J., Unemo, M.
Antimicrobial consumption - Annual Epidemiological Report for 2018
In 2018, the average total consumption (community and hospital sector combined) of antibacterials for systemic use (ATC group J01) in the EU/EEA was 20.1 DDD per 1 000 inhabitants per day (country range: 9.7–34.0). During the period 2009–2018, no statistically significant change was observed for the EU/EEA overall.